A new trading day began on Tuesday, with Nuvation Bio Inc (NYSE: NUVB) stock price down -6.76% from the previous day of trading, before settling in for the closing price of $8.58. NUVB’s price has ranged from $1.54 to $8.95 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -49.14% over the past five years. Meanwhile, its annual earnings per share averaged 71.47%. With a float of $239.22 million, this company’s outstanding shares have now reached $341.76 million.
Nuvation Bio Inc (NUVB) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Nuvation Bio Inc is 30.43%, while institutional ownership is 53.83%. The most recent insider transaction that took place on Dec 01 ’25, was worth 1,173,255. In this transaction CHIEF MEDICAL OFFICER of this company sold 150,000 shares at a rate of $7.82, taking the stock ownership to the 18,000 shares. Before that another transaction happened on Dec 01 ’25, when Company’s Officer proposed sale 150,000 for $7.82, making the entire transaction worth $1,173,255.
Nuvation Bio Inc (NUVB) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.12 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 71.47% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 55.84% during the next five years compared to -49.14% drop over the previous five years of trading.
Nuvation Bio Inc (NYSE: NUVB) Trading Performance Indicators
Here are Nuvation Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 102.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.64, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.51 in one year’s time.
Technical Analysis of Nuvation Bio Inc (NUVB)
Nuvation Bio Inc (NYSE: NUVB) saw its 5-day average volume 7.06 million, a positive change from its year-to-date volume of 5.6 million. As of the previous 9 days, the stock’s Stochastic %D was 68.25%.
During the past 100 days, Nuvation Bio Inc’s (NUVB) raw stochastic average was set at 85.94%, which indicates a significant increase from 76.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.67 in the past 14 days, which was higher than the 0.33 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.33, while its 200-day Moving Average is $3.08. Nevertheless, the first resistance level for the watch stands at $8.54 in the near term. At $9.08, the stock is likely to face the second major resistance level. The third major resistance level sits at $9.36. If the price goes on to break the first support level at $7.73, it is likely to go to the next support level at $7.45. Assuming the price breaks the second support level, the third support level stands at $6.91.
Nuvation Bio Inc (NYSE: NUVB) Key Stats
With a market capitalization of 2.75 billion, the company has a total of 342,833K Shares Outstanding. Currently, annual sales are 7,870 K while annual income is -567,940 K. The company’s previous quarter sales were 13,120 K while its latest quarter income was -55,790 K.
